Altimmune (ALT)
(Delayed Data from NSDQ)
$7.22 USD
-0.50 (-6.48%)
Updated May 10, 2024 04:00 PM ET
After-Market: $7.23 +0.01 (0.14%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Earnings News For ALT
-
Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Altimmune (ALT) to Report Q4 Earnings: What's in the Cards?
-
Alternus Energy Reports Third Quarter 2023 Financial Results
-
Altimmune, Inc. (ALT) Reports Q3 Loss, Misses Revenue Estimates
-
Altimmune, Inc. (ALT) Reports Q2 Loss, Misses Revenue Estimates
-
Altimmune, Inc. (ALT) Reports Q1 Loss, Misses Revenue Estimates
-
Altimmune, Inc. (ALT) Reports Q4 Loss, Tops Revenue Estimates
-
Analysts Estimate Altimmune, Inc. (ALT) to Report a Decline in Earnings: What to Look Out for
-
Altimmune, Inc. (ALT) Reports Q3 Loss, Tops Revenue Estimates
-
Altimmune, Inc. (ALT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Altimmune, Inc. (ALT) Reports Q2 Loss, Misses Revenue Estimates
-
Will Altimmune, Inc. (ALT) Report Negative Q2 Earnings? What You Should Know
-
Altimmune, Inc. (ALT) Reports Q1 Loss, Misses Revenue Estimates
-
Earnings Preview: Altimmune, Inc. (ALT) Q1 Earnings Expected to Decline
-
Altimmune, Inc. (ALT) Reports Q4 Loss, Tops Revenue Estimates
-
Will Altimmune (ALT) Report Negative Earnings Next Week? What You Should Know